• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结肠癌治疗中的药物-微生物群相互作用:抗生素的影响

Drug-Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics.

作者信息

Mohamed Ali, Menon Harry, Chulkina Marina, Yee Nelson S, Pinchuk Irina V

机构信息

Division of Hematology-Oncology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

Mechanisms of Carcinogenesis Program, Division of Gastroenterology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Penn State Cancer Institute, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

出版信息

Biomedicines. 2021 Mar 5;9(3):259. doi: 10.3390/biomedicines9030259.

DOI:10.3390/biomedicines9030259
PMID:33807878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7999677/
Abstract

Colon adenocarcinoma is one of the most common malignancies, and it is highly lethal. Chemotherapy plays an important role in the treatment of colon cancer at various stages of the disease. The gut microbiome has emerged as a key player in colon cancer development and progression, and it can also alter the therapeutic agent's efficacy and toxicities. Antibiotics can directly and/or indirectly affect the balance of the gut microbiome and, therefore, the clinical outcomes. In this article, we provided an overview of the composition of the gut microbiome under homeostasis and the mechanistic links between gut microbiota and colon cancer. The relationship between the use of oral antibiotics and colon cancer, as well as the impact of the gut microbiome on the efficacy and toxicities of chemotherapy in colon cancer, are discussed. Potential interventions to modulate microbiota and improve chemotherapy outcomes are discussed. Further studies are indicated to address these key gaps in the field and provide a scientific basis for the design of novel microbiota-based approaches for prevention/use as adjuvant therapeutics for patients with colon cancer.

摘要

结肠癌是最常见的恶性肿瘤之一,且具有很高的致死性。化疗在结肠癌疾病各个阶段的治疗中发挥着重要作用。肠道微生物群已成为结肠癌发生和发展的关键因素,它还会改变治疗药物的疗效和毒性。抗生素可直接和/或间接影响肠道微生物群的平衡,进而影响临床结局。在本文中,我们概述了稳态下肠道微生物群的组成以及肠道微生物群与结肠癌之间的机制联系。讨论了口服抗生素的使用与结肠癌之间的关系,以及肠道微生物群对结肠癌化疗疗效和毒性的影响。还讨论了调节微生物群并改善化疗结果的潜在干预措施。需要进一步开展研究以填补该领域的这些关键空白,并为设计基于微生物群的新型预防方法/用作结肠癌患者的辅助治疗提供科学依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bfc/7999677/6604c71f0e8a/biomedicines-09-00259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bfc/7999677/77aa318c9ce7/biomedicines-09-00259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bfc/7999677/6604c71f0e8a/biomedicines-09-00259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bfc/7999677/77aa318c9ce7/biomedicines-09-00259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bfc/7999677/6604c71f0e8a/biomedicines-09-00259-g002.jpg

相似文献

1
Drug-Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics.结肠癌治疗中的药物-微生物群相互作用:抗生素的影响
Biomedicines. 2021 Mar 5;9(3):259. doi: 10.3390/biomedicines9030259.
2
Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis.肠道微生物群的调控揭示其在结肠癌发生中的作用。
mSphere. 2015 Nov 4;1(1). doi: 10.1128/mSphere.00001-15. eCollection 2016 Jan-Feb.
3
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?肠道微生物群:改善抗肿瘤治疗的新靶点?
Int J Mol Sci. 2019 Sep 17;20(18):4584. doi: 10.3390/ijms20184584.
4
Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?肠道微生物群能否解决传统草药口服生物利用度的难题?
J Ethnopharmacol. 2016 Feb 17;179:253-64. doi: 10.1016/j.jep.2015.12.031. Epub 2015 Dec 23.
5
Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.微生物组与结直肠癌:在癌变过程中的作用及临床潜力。
Mol Aspects Med. 2019 Oct;69:93-106. doi: 10.1016/j.mam.2019.05.001. Epub 2019 May 24.
6
Gut microbiota as an "invisible organ" that modulates the function of drugs.肠道微生物群作为一种“看不见的器官”,调节药物的功能。
Biomed Pharmacother. 2020 Jan;121:109653. doi: 10.1016/j.biopha.2019.109653. Epub 2019 Nov 22.
7
Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances.抗生素与人类肠道微生物群:生态失调与耐药性积累
Front Microbiol. 2016 Jan 12;6:1543. doi: 10.3389/fmicb.2015.01543. eCollection 2015.
8
The potential impact of gut microbiota on your health:Current status and future challenges.肠道微生物群对健康的潜在影响:现状与未来挑战。
Asian Pac J Allergy Immunol. 2016 Dec;34(4):249-264. doi: 10.12932/AP0803.
9
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.肠道微生物群作为2型糖尿病高血糖预防和治疗的靶点:从当前的人类证据到未来的可能性
Diabetologia. 2017 Jun;60(6):943-951. doi: 10.1007/s00125-017-4278-3. Epub 2017 Apr 22.
10
The microbiome and cancer for clinicians.微生物组与癌症:临床医师视角
Crit Rev Oncol Hematol. 2019 Sep;141:1-12. doi: 10.1016/j.critrevonc.2019.06.004. Epub 2019 Jun 8.

引用本文的文献

1
Lifestyle, dietary pattern and colorectal cancer: a case-control study.生活方式、饮食模式与结直肠癌:一项病例对照研究。
BMC Nutr. 2024 Oct 17;10(1):138. doi: 10.1186/s40795-024-00950-x.
2
Contribution of PKS+ to colon carcinogenesis through the inhibition of exosomal miR-885-5p.PKS+ 通过抑制外泌体 miR-885-5p 对结肠癌发生的作用。
Heliyon. 2024 Sep 2;10(18):e37346. doi: 10.1016/j.heliyon.2024.e37346. eCollection 2024 Sep 30.
3
Ceftazidime and Usnic Acid Encapsulated in Chitosan-Coated Liposomes for Oral Administration against Colorectal Cancer-Inducing .

本文引用的文献

1
Accelerates the Progression of Colitis-Associated Colorectal Cancer by Promoting EMT.通过促进上皮-间质转化加速结肠炎相关结直肠癌的进展
Cancers (Basel). 2020 Sep 23;12(10):2728. doi: 10.3390/cancers12102728.
2
Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?肠道微生物群与结肠癌:细菌蛋白毒素的作用?
Int J Mol Sci. 2020 Aug 27;21(17):6201. doi: 10.3390/ijms21176201.
3
Antibiotic Administration Routes and Oral Exposure to Antibiotic Resistant Bacteria as Key Drivers for Gut Microbiota Disruption and Resistome in Poultry.
包裹在壳聚糖包被脂质体中的头孢他啶和松萝酸用于口服抗结直肠癌诱导
Pharmaceuticals (Basel). 2024 Jun 19;17(6):802. doi: 10.3390/ph17060802.
4
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?根治性手术治疗 I-III 期结直肠癌时的抗生素使用:与结局相关吗?
BMC Cancer. 2024 Jun 26;24(1):769. doi: 10.1186/s12885-024-12550-w.
5
The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review.基于人群的研究中应用褪黑素进行癌症综合治疗的潜力及异质性挑战:结肠癌病例报告及文献复习。
Curr Oncol. 2024 Apr 3;31(4):1994-2023. doi: 10.3390/curroncol31040149.
6
Special Issue: The Role of Gut Microbiota in Gastrointestinal Cancers-From Pathogenesis to Therapeutic Perspectives.特刊:肠道微生物群在胃肠道癌症中的作用——从发病机制到治疗前景
Biomedicines. 2023 Nov 1;11(11):2950. doi: 10.3390/biomedicines11112950.
7
Impact of Colorectal Cancer Sidedness and Location on Therapy and Clinical Outcomes: Role of Blood-Based Biopsy for Personalized Treatment.结直肠癌的侧别和位置对治疗及临床结局的影响:基于血液活检在个性化治疗中的作用
J Pers Med. 2023 Jul 10;13(7):1114. doi: 10.3390/jpm13071114.
8
8-Methoxyflindersine-Induced Apoptosis and Cell Cycle Disorder Involving MAPK Signaling Activation in Human Colorectal Cancer Cells.8-甲氧基千里光堿诱导的人结直肠癌细胞凋亡和细胞周期紊乱涉及 MAPK 信号通路的激活。
Int J Mol Sci. 2023 Apr 28;24(9):8039. doi: 10.3390/ijms24098039.
9
The Colloquy between Microbiota and the Immune System in Colon Cancer: Repercussions on the Cancer Therapy.结肠癌中微生物群与免疫系统的对话:对癌症治疗的影响
Curr Pharm Des. 2022;28(43):3478-3485. doi: 10.2174/1381612829666221122115906.
10
Exploring the Inflammatory Pathogenesis of Colorectal Cancer.探索结直肠癌的炎症发病机制。
Diseases. 2021 Oct 30;9(4):79. doi: 10.3390/diseases9040079.
抗生素给药途径及口服暴露于抗生素抗性细菌是家禽肠道微生物群破坏和抗性组的关键驱动因素。
Front Microbiol. 2020 Jul 7;11:1319. doi: 10.3389/fmicb.2020.01319. eCollection 2020.
4
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.肠道微生物群调节:预防和治疗结直肠癌的新策略。
Oncogene. 2020 Jun;39(26):4925-4943. doi: 10.1038/s41388-020-1341-1. Epub 2020 Jun 8.
5
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.靶向抑制肠道细菌β-葡萄糖醛酸酶活性可增强抗癌药物疗效。
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7374-7381. doi: 10.1073/pnas.1918095117. Epub 2020 Mar 13.
6
Antibiotic use and risk of colorectal cancer: a meta-analysis of 412 450 participants.抗生素使用与结直肠癌风险:对412450名参与者的荟萃分析
Gut. 2020 Nov;69(11):2059-2060. doi: 10.1136/gutjnl-2020-320826. Epub 2020 Feb 28.
7
The impact of gut microbiota manipulation with antibiotics on colon tumorigenesis in a murine model.抗生素对肠道微生物群的操纵对小鼠模型结肠肿瘤发生的影响。
PLoS One. 2019 Dec 20;14(12):e0226907. doi: 10.1371/journal.pone.0226907. eCollection 2019.
8
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.
9
Neonatal Exposure to Amoxicillin Alters Long-Term Immune Response Despite Transient Effects on Gut-Microbiota in Piglets.新生仔猪暴露于阿莫西林可改变长期免疫反应,尽管对肠道微生物群有短暂影响。
Front Immunol. 2019 Sep 4;10:2059. doi: 10.3389/fimmu.2019.02059. eCollection 2019.
10
Baseline human gut microbiota profile in healthy people and standard reporting template.健康人群的基线肠道微生物群特征及标准报告模板。
PLoS One. 2019 Sep 11;14(9):e0206484. doi: 10.1371/journal.pone.0206484. eCollection 2019.